RxDoctor Payments Data

James Gilbert, MD

Family Medicine · Lawrenceburg, KYNPI 1033177126

Payments from drug & device makers

$8,496in general payments, 2019–2025

Across 592 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • GSK$822
  • Novo Nordisk$744
  • Boehringer Ingelheim$720
  • Lilly USA, LLC$559
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$8,42199%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,496 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$69,015
Medicare patients
208
Services billed
931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide99$135,518
EliquisApixaban85$68,994
JardianceEmpagliflozin51$60,818
FarxigaDapagliflozin Propanediol29$37,963
XareltoRivaroxaban27$28,790
Spiriva RespimatTiotropium Bromide32$23,357
MounjaroTirzepatide15$14,733
TrulicityDulaglutide11$10,528
Levothyroxine Sodium372$5,257
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$4,006
Pantoprazole Sodium276$3,921
Testosterone14$3,374
Varenicline Tartrate15$3,318
Valsartan110$3,075
Omeprazole290$3,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$744$135,51899 claims
Boehringer IngelheimJardiance, Spiriva Respimat$720$84,17683 claims
PfizerEliquis$522$68,99485 claims
AstraZenecaFarxiga$1,058$37,96329 claims
Johnson & JohnsonXarelto$530$28,79027 claims
Lilly USA, LLCMounjaro, Trulicity$559$25,26126 claims
AbbVieSynthroid$1,276$1,77523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Lawrenceburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →